Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening
-
Sadeq Vallian
Abstract
Phenylketonuria is an inherited metabolic disease, which is characterized by an increased level of serum phenylalanine. Quantitative measurement of phenylalanine in the serum of phenylketonuria patients is necessary to confirm the disease, and to distinguish phenylketonuria from other forms of hyperphenylalaninemia. In this study, we report a rapid and inexpensive micro-assay for simultaneous detection and quantitative measurement of serum phenylalanine on dry blood-spots. Analysis of the standard curve showed a broad linear range for phenylalanine from 120 to 1800μmol/L. Application of this method, the standard Guthrie bacterial inhibition assay and a high-performance liquid chromatography (HPLC) method for analysis of 34 samples from phenylketonuria patients and control samples produced comparable results, with the regression equation Y=0.994X+0.996. The advantage of this method over the Guthrie bacterial inhibition assay is its ability to measure serum phenylalanine quantitatively without false positive results. The method was successfully applied to dried blood-spots, serum and whole blood. The cost per sample is approximately 20–50 US cents, which is much less than for HPLC and commercial enzyme kits. The method can be automated, and is thus suitable for neonatal and mass screening for phenylketonuria, especially in developing countries where funding is a limiting factor.
References
1. Scriver CR, Waters PJ. Monogenic traits are not simple: lessons from phenylketonuria. Trends Genet 1996; 15:267–72.Suche in Google Scholar
2. PAHbd: Phenylalanine hydroxylase locus database. http://www.mcgill.ca/pahdbSuche in Google Scholar
3. Krause W, Halminski M, McDonald L, Dembure P, Salvo R, Freides D, et al. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. J Clin Invest 1985; 75:40–8.10.1172/JCI111695Suche in Google Scholar
4. Faden R, Chwalow AJ, Holtzman NA, Horn SD. A survey to evaluate parental consent as public policy for neonatal screening. Am J Public Health 1982; 72:1347–52.10.2105/AJPH.72.12.1347Suche in Google Scholar
5. Sarkissian CN, Shao Z, Blain F, Peevers R, Su H, Heft R, et al. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc Natl Acad Sci USA 1999; 96:2339–44.10.1073/pnas.96.5.2339Suche in Google Scholar
6. Scriver CR. Commentary on: a simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, by Robert Guthrie and Ada Susi [Pediatrics, 1963;32:318–43]. Pediatrics 1998; 102:236–7.10.1542/peds.102.S1.236Suche in Google Scholar
7. Randell EW, Lehotay DC. An automated enzymatic method on the Roche COBAS MIRA™ S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria. Clin Chem 1996; 29:133–8.Suche in Google Scholar
8. Madira WM, Xavier F, Stern J, Wilcox AH, Barron JL. Determination and assessment of the stability of phenylalanine and tyrosine in blood spots by HPLC. Clin Chem 1992; 38:2162–3.10.1093/clinchem/38.10.2162Suche in Google Scholar
9. Kok WT, Brinkman UA, Frei RW. Rapid determination of phenylalanine and tyrosine in urine and serum by HPLC with electrochemical detection. J Pharm Biochem Anal 1983; 1:368–72.10.1016/0731-7085(83)80049-1Suche in Google Scholar
10. McCaman M, Robins E. Fluorimetric method for the determination of phenylalanine in serum. J Lab Clin Med 1962; 59:885–90.Suche in Google Scholar
11. Gerasimova NS, Steklova IV, Tuuminen T. Fluorimetric method for phenylalanine assay adapted for phenylketonuria screening. Clin Chem 1989; 35:2112–5.10.1093/clinchem/35.10.2112Suche in Google Scholar
12. Rohr FJ, Allred EN, Turner M, Simmons J, Levy HL. Use of the Guthrie bacterial inhibition assay to monitor blood phenylalanine for dietary treatment of phenylketonuria. Screening 1996; 4:205–11.10.1016/0925-6164(96)00130-2Suche in Google Scholar
13. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32:318–43.10.1542/peds.32.3.338Suche in Google Scholar
14. Vallian S, Barahimi E, Moeini H. Phenylketonuria in Iranian population: a study in institutions for mentally retarded in Isfahan. Mutat Res 2003; 526:45–52.10.1016/S0027-5107(03)00015-0Suche in Google Scholar
15. Qu Y, Miller JB, Slocum RH, Shapira E. Rapid automated for quantitation of isoleucine, leucine, tyrosine and phenylalanine from dried blood filter paper specimens. Clin Chim Acta 1991; 203:191–8.10.1016/0009-8981(91)90291-JSuche in Google Scholar
16. Cook BC, Wilhit TR, Smith CH, Landt M. Reagent-induced variation in specificity of serum phenylalanine assays. Clin Chem 1995; 41:949–50.10.1093/clinchem/41.6.949Suche in Google Scholar
17. Hilton MA. Liquid chromatographic direct determination of phenylalanine and tyrosine in serum or plasma, with application to patients with phenylketonuria. Clin Chem 1982; 28:1215–8.10.1093/clinchem/28.5.1215Suche in Google Scholar
18. Giammanco G, Pignato S. Rapid identification of micro-organisms from urinary tract infections by beta-glucuronidase, phenylalanine deaminase, cytochrome oxidase and indole tests on isolation media. J Med Microbiol 1994; 41:389–92.10.1099/00222615-41-6-389Suche in Google Scholar
19. Drechsel H, Thieken A, Reissbrodt R, Jung G, Winkelmann G. Alpha-keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J Bacteriol 1993; 175:2727–33.10.1128/jb.175.9.2727-2733.1993Suche in Google Scholar
20. Dooley KC. Enzymatic method for phenylketonuria screening using phenylalanine dehydrogenase. Clin Biochem 1992; 25:271–6.10.1016/0009-9120(92)80032-CSuche in Google Scholar
21. Lee C. Enzymatic determination of L-phenylalanine in serum. Lab Med 1993; 24:301–4.10.1093/labmed/24.5.301Suche in Google Scholar
22. Holmgren G, Larsson A, Palmstiena M, Alm J. The frequency of PKU and hyperphenylalaninemia in Sweden. A study in institutions for mentally retarded as well as in neonates. Clin Gen 1976; 10:313–8.10.1111/j.1399-0004.1976.tb00054.xSuche in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Where does the evidence come from?
- NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer
- Plasma cell-free DNA as an indicator of severity of injury in burn patients
- Bivariate statistical approach to evaluate laboratory performance by analysis of standard curves in an External Quality Assurance program for quantitative assays based on real-time PCR with Taq-Man™ probes
- Erythrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677C→T genotype
- Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors
- APO A-V–1131T→C polymorphism frequency and its association with morbidity in a Brazilian elderly population
- Association study between fibronectin and coronary heart disease
- Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins
- Urinary calcium excretion in severe preeclampsia and eclampsia
- In vitro re-mineralization of demineralized bone matrix in human serum
- Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA
- Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure
- Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry
- Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening
- N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability
- A new quality control model using performance goals based on biological variation in External Quality Assurance Schemes
- Improvement in glycemic control over 11 years in patients monitored for diabetes in one county
- The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus
- Analytical performance of a new two-step ADVIA Centaur® estradiol immunoassay during ovarian stimulation
- EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 – 2005
- POX-Act assay and d-ROMs test – what are the facts?
- External quality control of urinary methyl malonic acid quantification – announcement of a pilot study
Artikel in diesem Heft
- Where does the evidence come from?
- NASBA: a novel approach to assess hormonal receptors and ERBB2 status in breast cancer
- Plasma cell-free DNA as an indicator of severity of injury in burn patients
- Bivariate statistical approach to evaluate laboratory performance by analysis of standard curves in an External Quality Assurance program for quantitative assays based on real-time PCR with Taq-Man™ probes
- Erythrocyte membrane acetylcholinesterase activity in subjects with MTHFR 677C→T genotype
- Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors
- APO A-V–1131T→C polymorphism frequency and its association with morbidity in a Brazilian elderly population
- Association study between fibronectin and coronary heart disease
- Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins
- Urinary calcium excretion in severe preeclampsia and eclampsia
- In vitro re-mineralization of demineralized bone matrix in human serum
- Measurement of serum amyloid A1 (SAA1), a major isotype of acute phase SAA
- Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure
- Measurement of serum testosterone using high-performance liquid chromatography/tandem mass spectrometry
- Quantitative bacterial micro-assay for rapid detection of serum phenylalanine on dry blood-spots: application in phenylketonuria screening
- N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability
- A new quality control model using performance goals based on biological variation in External Quality Assurance Schemes
- Improvement in glycemic control over 11 years in patients monitored for diabetes in one county
- The clinical usefulness of glucose tolerance testing in gestational diabetes to predict early postpartum diabetes mellitus
- Analytical performance of a new two-step ADVIA Centaur® estradiol immunoassay during ovarian stimulation
- EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 – 2005
- POX-Act assay and d-ROMs test – what are the facts?
- External quality control of urinary methyl malonic acid quantification – announcement of a pilot study
